Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
Ellen Weisberg(Harvard University), Paul W. Manley(Novartis (Switzerland)), Werner Breitenstein(Novartis (Switzerland)), Josef Brüggen(Novartis (Switzerland)), Sandra W. Cowan‐Jacob(Novartis (Switzerland)), Arghya Ray(Harvard University), Brian J.P. Huntly(Brigham and Women's Hospital), Doriano Fabbro(Novartis (Switzerland)), Gabriele Fendrich(Novartis (Switzerland)), Elizabeth Hall–Meyers(Harvard University), Andrew L. Kung(Boston Children's Hospital), Jürgen Mestan(Novartis (Switzerland)), George Q. Daley(Boston Children's Hospital), Linda M. Callahan(Harvard University), Laurie Catley(Harvard University), Cara Cavazza(Harvard University), Mohammed Azam(Boston Children's Hospital), Donna Neuberg(Harvard University), Renee D. Wright(Brigham and Women's Hospital), D. Gary Gilliland(Brigham and Women's Hospital), James D. Griffin(Harvard University)
Cited by 1,483Open Access